Mylab buys majority stake in POC testing system developers Sanskritech

"During the second wave, we saw overburdening of our testing systems. It became evident that decentralized testing would significantly improve access and turnaround times. Point-of-Care labs will be a game-changer in the diagnostics space. This acquisition will enable us to further strengthen our efforts to make point-of-care testing available everywhere in India including a remote village." said Hasmukh Rawal, Managing Director, Mylab.

Commenting on the acquisition, Pritam Kumawat, Founder of Sanskritech said, "Through our IoT based POC system, Swayam, we have been striving to leverage technology to create an easy access to basic healthcare at an affordable cost. We look forward to working closely with Mylab to make point-of-care testing available across the country."

As part of the deal, Mylab will acquire a majority stake in Sanskritech in all-cash deal. Sansktitech team will continue to operate as a separate entity under the aegis of Mylab.

Mylab plans to establish more than 1000 POC systems in the next two years and start deployment of these systems with lab partners as early as November 2021.

These POC systems will offer a comprehensive range of tests including:

• Blood tests – Blood Glucose, Hemoglobin, Lipid assay, Cardiac Marker assay, Full blood work, Liver function test, Hormonal assay, Thyroid, etc.
• Disease tests – Hepatitis B (HBV), Hepatitis C (HCV) and Human Immunodeficiency Virus (HIV), Malaria, Dengue, Chikungunya, Tuberculosis, Respiratory Diseases, Metabolic Diseases, Skin diseases, etc.
• Urine tests – Creatinine, Leukocytes, Protein, pH, Urine Calcium, etc.,
• Other – ENT, Skin Test, Vision Test, ECG 12 lead, Alcohol Detection, etc.
• Basic – Height, Weight, BMI, Blood Pressure, Temperature, etc.